Tri-Lustra

Per g Tretinoin 0.5 mg, hydroquinone 40 mg, fluocinolone acetonide 0.1 mg

Short-term treatment of moderate to severe melasma of the face, in the presence of measures for sun avoidance, including sunscreen use.

Apply once daily at night, at least 30 min before bedtime. Apply a thin film to hyperpigmented areas of melasma including about ½ inch of normal-appearing skin surrounding each lesion. Rub lightly & uniformly into skin.

Do not use occlusive dressing. Because melasma usually recurs upon treatment discontinuation, patients should avoid sunlight exposure, use sunscreen w/ appropriate SPF, wear protective clothing, & switch to non-hormonal forms of birth control if hormonal methods are used. Safety & efficacy have not been studied in patients w/ skin types V & VI, & in the treatment of hyperpigmentation conditions other than melasma of the face. Excessive bleaching resulting in undesirable cosmetic effect in patients w/ darker skin cannot be excluded. Safety & efficacy have not been established in pregnant women & nursing mothers.

Other Dermatologicals

D11AX - Other dermatologicals ; Used in the treatment of dermatological diseases.

P₁S₁S₃